中国病理生理杂志
中國病理生理雜誌
중국병리생리잡지
CHINESE JOURNAL OF PATHOPHYSIOLOGY
2010年
3期
524-528
,共5页
贾旭广%石璐%林丽娜%汪洋%许益笑%王万铁
賈旭廣%石璐%林麗娜%汪洋%許益笑%王萬鐵
가욱엄%석로%림려나%왕양%허익소%왕만철
川芎嗪%肺动脉高压%细胞凋亡%胱硫醚-γ-裂解酶%硫化氢
川芎嗪%肺動脈高壓%細胞凋亡%胱硫醚-γ-裂解酶%硫化氫
천궁진%폐동맥고압%세포조망%광류미-γ-렬해매%류화경
Ligustrazine%Pulmonary hypertension%Apoptosis%Cystanthionine-γ-splitting enzyme%Hydrogen sulfide
目的:研究低O_2高CO_2性肺动脉高压时大鼠肺组织内硫化氢体系的变化及川芎嗪对其的干预作用.方法:将30只SD大鼠随机分为3组,每组10只.正常对照组(C组)、低O_2高CO_2组(HH组)、低O_2高CO_2+川芎嗪组(HH+LTZ组).监测其血流动力学变化,光镜观察肺细小动脉管壁面积/管总面积比值(WA/TA),检测右心室/ 左心室+室间隔(RV/ LV+SP) 比值,原位缺口末端标记法(TUNEL法)观测肺细小动脉凋亡情况,并计算凋亡指数.敏感硫电极法测定血浆H_2S含量及肺组织匀浆胱硫醚-γ-裂解酶(CSE)活性变化.RT-PCR法测定肺组织中CSE基因表达水平.结果:HH组的肺平均动脉压(mPAP)、WA/TA、RV/ LV+SP明显高于C组,HH+LTZ组明显低于HH组(均P<0.01);3组的平均颈动脉压(mCAP)无明显差异(P>0.05).TUNEL法测得HH组、HH+LTZ组的肺细小动脉凋亡指数(AI)显著低于C组(P<0.01), HH+LTZ组肺细小动脉凋亡指数显著高于HH组(P<0.05).血浆硫化氢(H_2S)含量、肺组织匀浆胱硫醚-γ-裂解酶(CSE)活性、肺组织CSE基因表达水平,HH组明显低于C组(P<0.01),HH+LTZ组明显高于HH组(P<0.01).结论:川芎嗪可能通过上调CSE基因表达,增加CSE的活性,提高H_2S水平,从而降低低O_2高CO_2性肺动脉高压.
目的:研究低O_2高CO_2性肺動脈高壓時大鼠肺組織內硫化氫體繫的變化及川芎嗪對其的榦預作用.方法:將30隻SD大鼠隨機分為3組,每組10隻.正常對照組(C組)、低O_2高CO_2組(HH組)、低O_2高CO_2+川芎嗪組(HH+LTZ組).鑑測其血流動力學變化,光鏡觀察肺細小動脈管壁麵積/管總麵積比值(WA/TA),檢測右心室/ 左心室+室間隔(RV/ LV+SP) 比值,原位缺口末耑標記法(TUNEL法)觀測肺細小動脈凋亡情況,併計算凋亡指數.敏感硫電極法測定血漿H_2S含量及肺組織勻漿胱硫醚-γ-裂解酶(CSE)活性變化.RT-PCR法測定肺組織中CSE基因錶達水平.結果:HH組的肺平均動脈壓(mPAP)、WA/TA、RV/ LV+SP明顯高于C組,HH+LTZ組明顯低于HH組(均P<0.01);3組的平均頸動脈壓(mCAP)無明顯差異(P>0.05).TUNEL法測得HH組、HH+LTZ組的肺細小動脈凋亡指數(AI)顯著低于C組(P<0.01), HH+LTZ組肺細小動脈凋亡指數顯著高于HH組(P<0.05).血漿硫化氫(H_2S)含量、肺組織勻漿胱硫醚-γ-裂解酶(CSE)活性、肺組織CSE基因錶達水平,HH組明顯低于C組(P<0.01),HH+LTZ組明顯高于HH組(P<0.01).結論:川芎嗪可能通過上調CSE基因錶達,增加CSE的活性,提高H_2S水平,從而降低低O_2高CO_2性肺動脈高壓.
목적:연구저O_2고CO_2성폐동맥고압시대서폐조직내류화경체계적변화급천궁진대기적간예작용.방법:장30지SD대서수궤분위3조,매조10지.정상대조조(C조)、저O_2고CO_2조(HH조)、저O_2고CO_2+천궁진조(HH+LTZ조).감측기혈류동역학변화,광경관찰폐세소동맥관벽면적/관총면적비치(WA/TA),검측우심실/ 좌심실+실간격(RV/ LV+SP) 비치,원위결구말단표기법(TUNEL법)관측폐세소동맥조망정황,병계산조망지수.민감류전겁법측정혈장H_2S함량급폐조직균장광류미-γ-렬해매(CSE)활성변화.RT-PCR법측정폐조직중CSE기인표체수평.결과:HH조적폐평균동맥압(mPAP)、WA/TA、RV/ LV+SP명현고우C조,HH+LTZ조명현저우HH조(균P<0.01);3조적평균경동맥압(mCAP)무명현차이(P>0.05).TUNEL법측득HH조、HH+LTZ조적폐세소동맥조망지수(AI)현저저우C조(P<0.01), HH+LTZ조폐세소동맥조망지수현저고우HH조(P<0.05).혈장류화경(H_2S)함량、폐조직균장광류미-γ-렬해매(CSE)활성、폐조직CSE기인표체수평,HH조명현저우C조(P<0.01),HH+LTZ조명현고우HH조(P<0.01).결론:천궁진가능통과상조CSE기인표체,증가CSE적활성,제고H_2S수평,종이강저저O_2고CO_2성폐동맥고압.
AIM: To investigate the effect of ligustrazine on hydrogen sulfide (H_2S) system in pulmonary hypertension induced by hypoxic hypercapnia in rats. METHODS: Thirty Sprague-Dawley rats were randomly divided into 3 groups: control group (C), hypoxic hypercapnia group (HH), and hypoxic hypercapnia+ligustrazine group (HH+L). The change of hemodynamics was measured. The ratio of vessel wall area and total area of arteriae pulmonalis were observed under light microscope. The apoptosis of arteriae pulmonalis was tested with TdT-mediated dUTP nick end labeling (TUNEL), and the apoptosis index was calculated. Plasma level of hydrogen sulfide and activity of hydrogen sulfide generating enzymes in homogenates of rat lung tissue were evaluated by sensitive modified sulfide electrode method. Cystathionine-γ-lyase (CSE) mRNA in lung tissues was determined by RT-PCR. RESULTS: The level of mean pulmonary arterial pressure, the ratio of vessel wall area/total area and the right ventricle/left ventricle+septum were significantly higher in HH group than those in C group, and the value was obviously lower in HH+LTZ group than that in HH group (all P<0.01). The mean carotid arterial pressure of 3 groups had no significant difference (P>0.05). The apoptotic index of arteriae pulmonalis in HH group and HH+LTZ group was significantly lower than that in C group, and that in HH+LTZ group was significantly higher than that in HH group (P<0.05 or P<0.01). Plasma level of H_2S, the activity of H_2S generating enzymes in homogenates of rat lung tissue, cystathionine-γ-lyase (CSE) mRNA in lung tissues in HH group were significantly lower than those in C group (all P<0.01), and those in HH+LTZ group were significantly lower than those in HH group (all P<0.01). CONCLUSION: Ligustrazine up-regulates the expression of cystanthionine-γ-splitting enzyme (CSE), enhances the activity of CSE and increases the level of H_2S to prevent pulmonary hypertension induced by hypoxic hypercapnia.